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Background: To investigate the three-dimensional (3D) distribution patterns of clinically metastatic (positive) lymph
nodes on pretreatment computed tomography (CT)/magnetic resonance imaging (MRI) images of patients with
locally advanced cervical cancer.
Methods: We enrolled 114 patients with uterine cervical cancer with positive nodes by CT/MRI (≥10 mm in the
shortest diameter). Pretreatment CT/MRI data were collected at 6 institutions. The FIGO stage was IB1 in 2 patients
(2%), IB2 in 6 (5%), IIA in 3 (3%), IIB in 49 (43%), IIIB in 50 (44%), and IVA in 4 (4%) patients. The median cervical
tumor diameter assessed by T2-weighted MRI was 55 mm (range, 10–87 mm). The anatomical distribution of the
positive nodes was evaluated on CT/MRI images by two radiation oncologists and one diagnostic radiologist.
Results: In these patients, 273 enlarged nodes were assessed as positive. The incidence of positive nodes was
104/114 (91%) for the obturator region, 31/114 (27%) for the external iliac region, 16/114 (14%) for the internal iliac
region, 22/114 (19%) for the common iliac region, and 6/114 (5%) for the presacral region. The external iliac region
was subdivided into four sub-regions: lateral, intermediate, medial, and caudal. The obturator region was subdivided
into two sub-regions: cranial and caudal. The majority of patients had positive nodes in the cranial obturator and/or
the medial external iliac region (111/114). In contrast, few had positive nodes in the lateral external iliac, caudal
external iliac, caudal obturator, internal iliac and presacral regions. All cases with positive nodes in those low-risk
regions also had positive nodes in other pelvic nodal regions concomitantly. The incidence of positive nodes in the
low-risk regions/sub-regions was significantly related to FIGO stage (p=0.017) and number of positive nodes
(p<0.001).
Conclusions: We demonstrated the 3D distribution patterns of clinical metastatic pelvic lymph nodes on
pretreatment CT/MRI images of patients with locally advanced cervical cancer. These findings might contribute to
future individualization of the clinical target volume of the pelvic nodes in patients with cervical cancer.
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FIGO=Federation Internationale de Gynecologie et de Obstetrique.
SCC=Squamous cell carcinoma.
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Radiotherapy plays very important roles in the treatment
of uterine cervical cancer. Definitive radiotherapy for
cervical cancer consists of external beam radiotherapy
and intracavitary brachytherapy. Recently, external beam
radiotherapy techniques have advanced considerably, as
have those for intracavitary brachytherapy. Treatment
planning for uterine cervical cancer has transitioned
from a two-dimensional (2D) approach based on bony
landmarks to a three-dimensional (3D) technique based
on computed tomography (CT)/magnetic resonance im-
aging (MRI). Intensity-modulated radiotherapy (IMRT)
has been proven to have a significant dosimetric advan-
tage and less toxicity compared with conventional 2D/
3D treatment planning for various malignancies, includ-
ing gynecologic cancers [1]. It is essential to define the
proper clinical target volume (CTV) for appropriate de-
livery of IMRT. Guidelines that provide a standard defin-
ition of CTV nodes are now published by the Radiation
Therapy Oncology Group (RTOG) [2], UK investigators
[3] and the Japan Clinical Oncology Group (JCOG) [4].
However, these guidelines were developed mainly from
information on the normal anatomical pelvic lymph
node distribution. The actual distribution of clinically
metastatic (positive) nodes in the pelvis has not been
studied in definitive radiotherapy series. If areas with a
low risk of node metastases could be deleted from the
CTV, toxicity could be reduced without sacrificing re-
gional control.
The purpose of this study was to investigate the 3D
distribution patterns of clinically metastatic nodes
assessed by CT/MRI in patients with uterine cervical
cancer.
Methods
We enrolled 114 patients with uterine cervical cancer
who were diagnosed as having clinically metastatic (posi-
tive) pelvic nodes by CT/MRI (≥10 mm in the shortest
diameter) and treated by definitive radiotherapy/
chemoradiotherapy at 6 institutions between January
2001 and December 2007. This study conformed to the
ethical principles contained in the Declaration of
Helsinki [5], and was approved by the institutional re-
view board of the principal investigator (T.T.). Lymph
nodes greater than or equal to 10 mm in the shortest
diameter, as assessed by CT/MRI, were defined as posi-
tive in this study. Patient characteristics are summarized
in Table 1. Digitized CT/MRI images burned to CD-
ROMs were collected from each institution. The images
were reviewed by two radiation oncologists (G.K., T.T.)
and one diagnostic radiologist (A.Y.).
Pelvic lymph node area was divided into five anatom-
ical regions: the obturator region, the external iliac re-
gion, the internal iliac region, the common iliac region,and the presacral region. The external iliac was further
divided into four sub-regions: the medial external iliac,
the intermediate external iliac, the lateral external iliac,
and the caudal external iliac. The subcategories of med-
ial external iliac, intermediate external iliac, and lateral
external iliac refer to the definitions proposed by Taylor
et al. [6] and Lengelé et al. [7]: medial external iliac=the
dorsal area of attachment and along the external iliac
vein, intermediate external iliac=the anterior area be-
tween the external iliac artery and vein, and lateral exter-
nal iliac=the lateral area of the external iliac artery.
These three sub-regions are all located cranial to the as-
pect of the femoral head. On the other hand, the caudal
external iliac is located caudal to the aspect of the fem-
oral head. The obturator was also divided into two sub-
regions, with the border of the aspect of the femoral
head as the external iliac: cranial obturator and caudal
obturator. An atlas of these sub-regions (except for com-
mon iliac region) is presented in Figure 1 (a)-(b).
First, the number of positive nodes in each region and










OB=obturatorregion, EI = external iliac region, lat-EI = lateral external iliac 
region, int-EI = intermediate external iliac region, med-EI = medial external  
iliac region, InI= internal iliac region, PS = presacralregion 
Figure 1 Atlas of the CTV nodes: regions and sub-regions. Middle-level of pelvis' for (a), and 'low-level of pelvis' for (b).
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area.
Statistical analyses were performed with the chi-square
test. A probability level of 0.05 was chosen for statistical
significance.
Results
There were 273 positive nodes as assessed by CT/MRI.
The median number of positive nodes per patient was 2
(range, 1–7). Figure 2 shows the incidence of positive
nodes in each nodal region. The area that most fre-
quently contained positive nodes was the obturator re-
gion. In contrast, positive nodes were rarely observed in
the presacral region. Table 2 shows the anatomicaldistribution of positive nodes in the pelvis. A solitary
positive node was observed only in the obturator and
the external iliac regions. In contrast, no solitary positive
node was observed in the internal iliac, common iliac,
and presacral regions. Within the obturator and external
iliac regions, positive nodes were rarely observed in the
caudal and lateral external iliac sub-regions. Ninety-
seven percent of the patients (111/114) had one or more
positive nodes in the cranial obturator and/or the medial
external iliac regions. A solitary positive node was
observed only in the cranial obturator, and medial/
intermediate external iliac regions. For other regions
or sub-regions, patients with positive nodes also had
positive nodes concomitantly in other pelvic nodal
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OB = obturator region, EI = external iliac region, InI = internal iliac region, 
CI = common iliac region, PS = presacral region
Figure 2 Incidence of clinically metastatic pelvic lymph nodes in each region. *Including duplication.
Kasuya et al. Radiation Oncology 2013, 8:139 Page 4 of 6
http://www.ro-journal.com/content/8/1/139regions or sub-regions. We defined each of these regions
as a NSR (non-solitary region). Patients with NSR metas-
tases had high FIGO stages or a large number of positive
nodes. Patients with high FIGO-stage disease (III, IVA)
had a significantly higher frequency of positive nodes in
the NSR (23/54, 43%) compared with patients who had
low FIGO-stage disease (15/60, 25%) (P=0.047). The aver-
age number of metastatic lymph nodes was 3.7 for pa-
tients with NSR and 1.9 for patients with non-NSR. There
was no significant relationship between tumor diameter
and the incidence of NSR metastases: 6/18 (30%) for tu-
mors≤40 mm, 20/58 (34%) for tumors 41–60 mm, and
15/38 (38%) for tumors≥61 mm. All 16 patients with
nodal metastases in less common (≤ 6/114, 5%) areas
(presacral, caudal obturator, and caudal/lateral external
iliac regions) had large tumors (> 4 cm), of which all 9
cases who had NSR metastases in the lateral external iliac
and presacral regions were stage IIB or more. In addition,
all 9 cases with NSR metastases in the caudal obturator or
caudal external iliac regions also had positive lymph nodes
in the ipsilateral cranial obturator or medial external iliac
region, and all 3 cases with NSR metastases in the lateral
external iliac region had positive nodes in the ipsilateral
intermediate external iliac region.Table 2 Number of patients* with clinically pelvic nodal meta
Total OB
Cranial Caudal
Positive nodes in other regions 82 76 5
No positive nodes in other regions 32 28 0
Total 114 104 5
*including duplication, # assesed by CT/MRI (>= 10 mm in shortest diameter).
OB = obturator region, EI = external iliac region, InI = internal iliac region, CI = com
Lat = lateral.Discussion
To minimize the risk of inter-planner variability on pel-
vic node CTV contouring, consensus-based CTV guide-
lines have been developed for patients with cervical
cancer [2-4]. Modification of the standard CTV guide-
lines based on the probability of subclinical disease, in
other words, risk of recurrence is the next challenge for
individualized treatment planning.
The CTV could be divided into subgroups, e.g., high-
risk CTV and low-risk CTV, according to the probability
of recurrence. The high-risk CTV would be defined as
the volume that involves frequent metastases, and
should be treated for every patient. In contrast, the low-
risk CTV would be defined as a region with rare disease
involvement, and might be able to be excluded from the
CTV in certain situations. The arrangement of CTV
nodes could reduce the dose/volume of organs at risk
(OAR) and lead to lower side effects. In the previously
published guidelines, the CTV nodes cover the entire
anatomical pelvic node distribution [2-4,6]. The guide-
lines did not emphasize the actual probability of nodal
involvement, in other words, the risk of recurrence. In
head and neck cancers, individualization of CTV nodes
for 3D planning was proposed according to the primarystases # by region/subdivided region
EI InI CI PS
Med Int Lat Caudal
10 13 3 6 16 22 6
2 2 0 0 0 0 0
12 15 3 6 16 22 6
mon iliac region, PS = presacral region, Med = medial, Int = intermediate,
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attempt at dose reduction for OAR, small pelvic field ir-
radiation has been investigated [9,10]. The treatment
fields were designed to exclude the common iliac region.
In this study, we tried to analyze the 3D distribution pat-
terns of positive nodes in the pelvis assessed by pretreat-
ment CT/MRI to quantify the nodal metastasis
probability in patients with uterine cervical cancer.
Some surgical series have indicated that the obturator
and external iliac regions have the highest frequency of
metastatic lymph nodes [11,12]. This is consistent with
the findings demonstrated in the present study. We
subdivided the obturator and external iliac regions
according to craniocaudal distribution at the border of
the femoral head. Analyses with this subdivision revealed
that positive lymph nodes were rarely seen on the caudal
side, and most were observed on the cranial side.
Benedetti and colleagues also subdivided the obturator
region into deep and superficial regions. They demon-
strated that there were few metastatic lymph nodes in
the deep region [12]. Our results are consistent with that
report. No previous study supports our finding that the
caudal external iliac sub-region rarely had positive
nodes. However, the present results suggest the appro-
priateness of the definition of the external iliac region in
the RTOG and JCOG guidelines, which set the lower
end of the external iliac region at the top of the femoral
head [2,4].
For the external iliac region above the aspect of the
femoral head, 3 anatomically subdivided regions have
been proposed [6,7]. According to the definition, positive
nodes in the medial external iliac and intermediate ex-
ternal iliac regions were frequent in contrast to the lat-
eral external iliac regions in our study. This observation
was also made by Graham et al. [13]. Taylor et al. dem-
onstrated that the normal node distribution extended
more than 10 mm laterally to the external iliac artery
and veins in their USPIO MRI study. Based on this find-
ing, they recommended that the CTV should expand 17
mm laterally from the vessels to cover the region suffi-
ciently [6]. However, our present study demonstrated
that positive nodes were rare in the lateral external iliac
region, and suggested that the expansion that Taylor
proposed could be omitted in some cases.
Based on the findings from our present analyses, high-
risk regions such as the cranial obturator and the medial
and intermediate external regions must be irradiated suf-
ficiently in all cases. In contrast, the caudal external iliac,
caudal obturator, lateral external iliac and presacral re-
gions, which demonstrated a very low incidence (≤ 5%)
of positive nodes, might be allowed to be excluded in pa-
tients who satisfy all of the following criteria: small
tumor size (≤ 4 cm) and no positive nodes on CT/MRI.
The CTV shrinkage might help to reduce complicationsin the surrounding organs. Further investigation is
needed to justify such modification in clinical practice.
In the other remaining regions (i.e., common iliac, in-
ternal iliac), although no patient in this study had a soli-
tary positive lymph node, the positive rate was not low.
Therefore, we suggest that the common iliac and in-
ternal iliac regions should continue to be included in all
cases for radical radiotherapy for patients with uterine
cervical cancer.
This study has some limitations. First, the insufficient
sensitivity of CT/MRI is critical. Bellomi and colleagues
reported that the sensitivity and specificity of CT were
64% and 93%, respectively, and those of MRI were 72%
and 93%, respectively [14]. The results of this study
should be interpreted carefully due to the inadequate
sensitivity and specificity of these methods. Meanwhile,
Choi and coworkers compared the sensitivity and speci-
ficity of MRI and positron emission tomography/com-
puted tomography (PET/CT) [15]. With MRI, the
sensitivity and specificity were 30% and 92%, respect-
ively, and with PET/CT, the sensitivity and specificity
were 57% and 92%, respectively. Further study using
PET/CT is encouraged. Second, the absence of histo-
pathological confirmation is a serious weakness of the
present study. Although some surgical series presented
detailed data on the pathological positive node distribu-
tion [11,12], data for inoperable advanced-stage patients
were sparse. In addition, it is difficult to apply the distri-
bution of metastatic nodes from surgical findings dir-
ectly to the 3D distribution on CT/MRI images for
accurate CTV contouring. For these reasons, despite its
insufficient sensitivity and specificity, some surrogate in-
formation could be obtained from the study using CT/
MRI. Third, this study consists of a relatively small num-
ber of patients and a heterogenous population (i.e. stage,
tumor size). Various systematic and random errors due
to multicenter assessment over a long time period might
negatively affect the validity of the study.
Conclusions
The present study demonstrated distribution patterns of
positive pelvic nodes in patients with cervical cancer
treated with definitive radiotherapy/chemoradiotherapy.
The findings might contribute to future investigations
for the individualization of CTV node contouring.
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